BLOG

biotech 2050

New approaches in CNS diseases, Brad Margus, Co-founder and Executive Chairman, Cerevance

Brad Margus is co-founder and Executive Chairman of Cerevance, a drug discovery company advancing a robust pipeline of targeted treatments for patients with neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease.